KeyBanc on American Healthcare REIT, Inc (AHR): 'Another Quarter of Strong Execution'

KeyBanc analyst Austin Wurschmidt reiterated an Overweight rating and $43.00 price target on American Healthcare REIT, Inc (NYSE: AHR).

The analyst commented: "Another Quarter of Strong Execution; Investment Momentum Continues into Late ‘25; AHR continues to execute on all fronts, which culminated with a 3Q beat, ’25 NFFO guidance increase, and growing pipeline of future investments tracking well ahead of our assumption. A 150 bps increase to SSNOI growth guidance to 14% was led by a 300 bps increase to SHOP and 150 bps increase from ISHCs (~75% of SSNOI). With $450M of awarded deals projected to close by YE25 and ~$120M of (re)development starts, AHR’s strong balance sheet and attractive cost of capital are in position to accretively fund future deals. We expect the stock to outperform the Healthcare REITs in tomorrow’s trading."

For an analyst ratings summary and ratings history on American Healthcare REIT, Inc click here. For more ratings news on American Healthcare REIT, Inc click here.

Shares of American Healthcare REIT, Inc closed at $47.92 yesterday.

You May Also Be Interested In

• Golar LNG Ltd. (GLNG) PT Raised to $70 at BTIG
• Avalonbay Communities (AVB) dropped from S&P 500
• zSpace, Inc. (ZSPC) Reports Q2 results